Eli Lilly (LLY) Receivables - Other (2009 - 2026)
Eli Lilly (LLY) recorded Receivables - Other of $3.14 billion in Q3 2026, down 6.2% from $3.35 billion a year earlier and down 7.4% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Receivables - Other (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly reported Receivables - Other of $2.4 billion, up 5.5% from FY2024.
- Annual Receivables - Other has increased for six straight years, with a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $2.27 billion in FY2024 (+1.1%), $2.25 billion in FY2023 (+35.0%), $1.66 billion in FY2022 (+14.3%) and $1.45 billion in FY2021 (+38.0%).
- Quarterly Receivables - Other has ranged from $1.31 billion in Q2 2022 to $3.39 billion in Q2 2026 over the past five years.
- On a year-over-year basis, Receivables - Other rose in six of the last eight quarters, with growth averaging 22.9%.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 90.7% in Q3 2025, against a decline of 20.0% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.39 billion (Q2 2026), $2.75 billion (Q1 2026) and $2.4 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.14 Bn |
| Jun 30, 2026 | 3.39 Bn |
| Mar 31, 2026 | 2.75 Bn |
| Dec 31, 2025 | 2.40 Bn |
| Sep 30, 2025 | 3.35 Bn |
| Jun 30, 2025 | 3.04 Bn |
| Mar 31, 2025 | 1.97 Bn |
| Dec 31, 2024 | 2.27 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 2.05 Bn |
| Mar 31, 2024 | 2.13 Bn |
| Dec 31, 2023 | 2.25 Bn |
| Sep 30, 2023 | 2.20 Bn |
| Jun 30, 2023 | 1.66 Bn |
| Mar 31, 2023 | 1.50 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.31 Bn |
| Mar 31, 2022 | 1.48 Bn |
| Dec 31, 2021 | 1.45 Bn |
API Access
Eli Lilly Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();